-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Market analysis of chemical machinery equipment network ] The pharmaceutical equipment industry is regarded as the "heart" of pharmaceutical production, which is of great significance to promote the development of the pharmaceutical industry.
In recent years, with the rapid development of the pharmaceutical industry, the upstream pharmaceutical equipment industry has also developed rapidly, and the performance of large pharmaceutical machinery companies has improved significantly.
Chemical machinery and equipment network market analysis chemical machinery and equipmentIn recent years, with the rapid development of the pharmaceutical industry, the upstream pharmaceutical equipment industry has also developed rapidly, and the performance of large pharmaceutical machinery companies has improved significantly.
Take Tofflon as an example.
From 2018 to 2020, the company's operating income was 19.
2, 22.
6, and 2.
71 billion yuan, with a compound annual growth rate of 18.
8%; net profits deducted from the parent were 0.
70, 1.
46, and 463 million yuan, respectively.
The growth rate was 157.
18%.
From 2018 to 2020, the company's operating income was 19.
2, 22.
6, and 2.
71 billion yuan, with a compound annual growth rate of 18.
8%; net profits deducted from the parent were 0.
70, 1.
46, and 463 million yuan, respectively.
The growth rate was 157.
18%.
Chutian Technology's performance in 2018-2020 has also achieved steady growth, achieving operating revenues of 16.
32, 19.
16, and 3.
576 billion yuan, respectively, with a compound annual growth rate of 48.
03%; net profits attributable to parent companies were 0.
41, 0.
49, and 201 million yuan, respectively, with a compound annual growth rate.
Speed 121.
41%.
32, 19.
16, and 3.
576 billion yuan, respectively, with a compound annual growth rate of 48.
03%; net profits attributable to parent companies were 0.
41, 0.
49, and 201 million yuan, respectively, with a compound annual growth rate.
Speed 121.
41%.
In addition, Canaan Technology achieved operating revenues of 5.
79, 7.
17, and 1.
007 billion yuan in 2018-2020; a compound annual growth rate of 31.
88%; net profits attributable to parent companies were 0.
34, 0.
82, and 68 million yuan, with a compound annual growth rate of 41.
42%.
79, 7.
17, and 1.
007 billion yuan in 2018-2020; a compound annual growth rate of 31.
88%; net profits attributable to parent companies were 0.
34, 0.
82, and 68 million yuan, with a compound annual growth rate of 41.
42%.
.
.
.
.
.
.
.
.
.
.
.
In 2021, as the pharmaceutical industry accelerates its transformation and upgrading driven by policies such as consistency evaluation and centralized procurement, as well as the intensification of the aging process, the level of drug use among urban and rural residents has gradually increased, the gap has gradually narrowed, and the demand for drugs has continued to maintain a relatively high rate of growth.
The demand for pharmaceutical equipment has also increased, coupled with the gradual increase in fixed asset investment in the pharmaceutical manufacturing industry, the revenue and orders of the pharmaceutical equipment industry are rising simultaneously.
Judging from the listed pharmaceutical machine companies that have disclosed the first quarter report of 2021, the pharmaceutical equipment industry showed a busy scene of production and delivery from January to March.
Most pharmaceutical machine companies maintained steady growth in their revenue in the first quarter and net profits.
The growth rate is also very impressive.
Pharmaceutical equipmentThe demand for pharmaceutical equipment has also increased, coupled with the gradual increase in fixed asset investment in the pharmaceutical manufacturing industry, the revenue and orders of the pharmaceutical equipment industry are rising simultaneously.
Judging from the listed pharmaceutical machine companies that have disclosed the first quarter report of 2021, the pharmaceutical equipment industry showed a busy scene of production and delivery from January to March.
Most pharmaceutical machine companies maintained steady growth in their revenue in the first quarter and net profits.
The growth rate is also very impressive.
With the disclosure of the 2020 annual reports of listed pharmaceutical machine companies and the first quarterly report of 2021, many pharmaceutical equipment companies have also received institutional attention.
For example, Canaan Technology announced on May 24 that on May 21, the company received surveys from two institutions; Chutian Technology disclosed the record of investor relations activities on May 24, and the company released it on May 21, 2021.
Accepted surveys from 23 institutions, and it has also accepted surveys from 4 institutions on May 18, 2021; Tofflon accepted surveys from 44 institutions on May 24, 2021.
From the content of the institutional research, the development situation, competitive advantages, pre-judgment of the industry and the future layout of the investigated companies have attracted considerable attention from the institutions.
For example, Canaan Technology announced on May 24 that on May 21, the company received surveys from two institutions; Chutian Technology disclosed the record of investor relations activities on May 24, and the company released it on May 21, 2021.
Accepted surveys from 23 institutions, and it has also accepted surveys from 4 institutions on May 18, 2021; Tofflon accepted surveys from 44 institutions on May 24, 2021.
From the content of the institutional research, the development situation, competitive advantages, pre-judgment of the industry and the future layout of the investigated companies have attracted considerable attention from the institutions.
In the long run, as the upstream of the pharmaceutical industry, the pharmaceutical equipment industry has both opportunities and challenges in the context of accelerated transformation and upgrading of the pharmaceutical industry and increased investment in fixed assets.
Opportunity: the pharmaceutical industry’s demand for equipment will continue to grow, especially the demand for high-end pharmaceutical equipment will usher in expansion, and the drug delivery machine industry will bring new development plans; on the challenge: on the one hand, drug quality requirements will continue to increase, and the industry Supervision is also becoming stricter, and pharmaceutical equipment is facing higher requirements in terms of safety, production efficiency, and stability; on the other hand, the domestic pharmaceutical equipment market has considerable room for development, and more and more overseas pharmaceutical machine manufacturers are influx In the market, the competition between domestic and overseas companies will become increasingly fierce, while China’s pharmaceutical machinery companies as a whole are still in the low-end stage.
The number of local companies in the mid-to-high-end field is small and the product competitiveness is weak.
How to accelerate the transition from low-end to mid-to-high-end is A big subject.
Opportunity: the pharmaceutical industry’s demand for equipment will continue to grow, especially the demand for high-end pharmaceutical equipment will usher in expansion, and the drug delivery machine industry will bring new development plans; on the challenge: on the one hand, drug quality requirements will continue to increase, and the industry Supervision is also becoming stricter, and pharmaceutical equipment is facing higher requirements in terms of safety, production efficiency, and stability; on the other hand, the domestic pharmaceutical equipment market has considerable room for development, and more and more overseas pharmaceutical machine manufacturers are influx In the market, the competition between domestic and overseas companies will become increasingly fierce, while China’s pharmaceutical machinery companies as a whole are still in the low-end stage.
The number of local companies in the mid-to-high-end field is small and the product competitiveness is weak.
How to accelerate the transition from low-end to mid-to-high-end is A big subject.
In general, the development prospects of the domestic pharmaceutical equipment market are worthy of recognition.
Recently, Industrial Securities mentioned in its research report that the pharmaceutical equipment market has entered a growth period of overall stability and partial breakthroughs: With the recovery of the upstream pharmaceutical industry, the Chinese pharmaceutical equipment market is expected to reach US$4.
58 billion in 2025, with a compound growth rate of 8.
1 %.
Recently, Industrial Securities mentioned in its research report that the pharmaceutical equipment market has entered a growth period of overall stability and partial breakthroughs: With the recovery of the upstream pharmaceutical industry, the Chinese pharmaceutical equipment market is expected to reach US$4.
58 billion in 2025, with a compound growth rate of 8.
1 %.
Original title: By 2025, China's pharmaceutical equipment market is expected to reach US$4.
58 billion
58 billion
